Abstract
Being frequent travelers, the elite athletes are advised to undergo an influenza vaccination. The aim of the study was to describe the antibody response to repeated trivalent, inactivated, split influenza vaccine, of different antigenic content, recommended for the Northern and the Southern Hemisphere, administered to sportsmen before the Olympic Games in Brasil in 2016. Fourteen athletes were included in the study. For both A/California/7/209/pdm09 A/H1N1/ antigen and A/Switzerland/971593/2013/A/H3N2/ antigen, higher seroconversion rates were obtained after the first than the second vaccination (10.2 vs. 1.5 and 10.6 vs. 3.0, respectively; p < 0.05 both). Conversion rates for B/Phuket/3073/2013, B/Brisbane/60/2008, and A/HongKong/4801/2014/A/H3N2/ antigens were lower. Nonetheless, the protection rate was greater than 70% for all antigens contained in both vaccines. The proportion of individuals demonstrating a high level of both protection rate and response rate was greater after the first than the second vaccination. We conclude that the immunological response after influenza vaccination is good in elite athletes and remains so after a second influenza vaccination required due to a different vaccine composition recommended for different hemispheres.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
ACIP (2017) American committee on immunization practices. Immunogenicity, efficacy, and effectiveness of influenza vaccines http://www.cdcgov/flu/professionals/acip/background/immunogenicityhtm. Accessed 23 Feb 2018)
Andrews SF, Kaur K, Pauli NT, Huang M, Huang Y, Wilson PC (2015) High preexisting serological antibody levels correlate with diversification of the influenza vaccine response. J Virol 89:3308–3317
Belongia EA, Skowronski DM, McLean HQ, Chambers C, Sundaram ME, De Serres G (2017) Repeated annual influenza vaccination and vaccine effectiveness: review of evidence. Expert Rev Vaccines 16:1–14
CPMP (1997) Committee for Proprietary Medicinal Products (CPMP/BWP/214/96). http://Note for Guidance on Harmonisation of Requirements for Influenza Vaccine. Accessed 2 May 2018
Gartner B, Meyer T (2014) Vaccination in elite athletes. Sports Med 44:1361–1376
Gleeson M, Williams C (2013) Intense exercise training and immune function. Nestle Nutr Inst Workshop Ser 76:39–50
Goeijenbier M, van Genderen P, Ward BJ, Wilder-Smith A, Steffen R, Osterhaus AD (2017) Travellers and influenza: risks and prevention. J Travel Med 24(1):pii: taw078
Gundlapalli AV, Rubin MA, Samore MH, Lopansri B, Lahey T, McGuire HL, Winthrop KL, Dunn JJ, Willick SE, Vosters RL, Waeckerle JE, Carroll KC, Gwaltney JM Jr, Hayden FG, Elstad MR, Sande MA (2006) Influenza, winter Olympiad, 2002. Emerg Infect Dis (1):144–146
Hackney AC (2013) Clinical management of immuno-suppression in athletes associated with exercise training: sports medicine considerations. Acta Med Iran 51:75175–75176
Huang KA, Chang SC, Huang YC, Chiu CH, Lin TY (2017) Antibody responses to trivalent inactivated influenza vaccine in health care personnel previously vaccinated and vaccinated for the first time. Sci Rep 18:40027
Marti F, Steffen R, Mutsch M (2008) Influenza vaccine: a travelers’ vaccine? Expert Rev Vaccines 7:679–687
Nitsch-Osuch A (2017) Influenza in sport. Pol J Sports Med 33:77–86
Nuñez IA, Carlock MA, Allen JD, Owino SO, Moehling KK, Nowalk P, Susick M, Diagle K, Sweeney K, Mundle S, Vogel TU, Delagrave S, Ramgopal M, Zimmerman RK, Kleanthous RTM (2017) Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains. PLoS One 1:11
Osterholm MT, Kelley NS, Sommer A, Belongia EA (2012) Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12:36–44
Powers DC, Belshe RB (1994) Vaccine-induced antibodies to heterologous influenza AH1N1 viruses: effects of aging and “original antigenic sin”. J Infect Dis 169:1125–1129
Ramsay LC, Buchan SA, Stirling RG, Cowling BJ, Feng S, Kwong JC, Warshawsky BF (2017) The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis. BMC Med 15(1):159
Ross TM, Lin CJ, Nowalk MP, Huang HH, Spencer SM, Shay DK (2014) Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50–80 years of age. Hum Vaccin Immunother 10:1195–1203
Tisa V, Barberis I, Faccio V, Paganino C, Trucchi C, Martini M, Ansaldi F (2016) Quadrivalent influenza vaccine: a new opportunity to reduce the influenza burden. J Prev Med Hyg 57:E28–E33
WHO (2011) Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza. WHO Press, Geneva, 1–153
WHO (2016) Recommendations on the composition of influenza virus vaccines. http://www.who.int/influenza/vaccines/virus/recommendations/en/. Accessed 27 Nov 2017
WHO (2017) http://www.who.int/mediacentre/news/releases/2017/seasonal-flu/en/. Accessed 8 Mar 2018
Conflicts of Interest
The authors declare no conflict of interests in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Krzywański, J. et al. (2018). Antibody Response to Trivalent Influenza Vaccine in the Northern and the Southern Hemisphere in Elite Athletes. In: Pokorski, M. (eds) Current Trends in Immunity and Respiratory Infections. Advances in Experimental Medicine and Biology(), vol 1108. Springer, Cham. https://doi.org/10.1007/5584_2018_223
Download citation
DOI: https://doi.org/10.1007/5584_2018_223
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-01634-0
Online ISBN: 978-3-030-01635-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)